Cryptosporidium parvum Mediated Diarrhea in Immunocompromised Patients
DOI:
https://doi.org/10.37591/rrjoi.v6i3.1291Abstract
Cryptosporidium parvum is one of the important diarrheal agents, especially in malnourished children and immunocompromised patients. Of the many species, Cryptosporidium parvum and Cryptosporidium hominis are the two major species that cause water borne outbreaks. The geographic difference in the distribution of parasite has been attributed to sources and its mode of transmission. The parasite is able to survive in the environment for long time and is resistant to many disinfectants. There is correlation between CD4 count of less than 200 cells per cubic mm and symptomatic cryptosporidiosis. In immunocompromised individuals like acquired immunodeficiency syndrome patients, the disease takes severe form. The diarrhoea is prolonged with dehydration and possible involvement of respiratory tract. Both innate and acquired immunity provide antiparasitic defence. Mucosal antibody response may be involved. Cell-mediated response and IFN-γ play a dominant role. Antimicrobial killing mechanisms include nitric oxide production and antimicrobial peptides. Acid fast staining is most commonly used method for diagnosis. Antigen detection kits are available with specificity of 93 to 100%. Nitazoxanide has been approved for treatment of diarrhea caused by Cryptosporidium in immunocompetent people. Preventive measures include protective personal and public hygienic measures. It is essential to screen potable water sources for the presence of parasite to prevent water borne outbreaks.
Keywords: Cryptosporidium parvum, diarrhea, immunocompromised, immune response, laboratory diagnosis, out breaks
Cite this Article
Durgadas Govind Naik. Cryptosporidium parvum Mediated Diarrhea in Immunocompromised Patients. Research & Reviews: Journal of Immunology. 2016; 6(3): 5–9p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |
